| DAVITA INC. DL -,001 |
| USA |
| Gesundheit |
| US23918K1088 / 897914 |
| TRL (Frankfurt) / DVA (NYSE) |
| FRA:TRL, ETR:TRL, TRL:GR, NYSE:DVA |
| S&P500 |
| https://www.davita.com/ |
|
DaVita Inc. is a leading healthcare provider specializing in kidney care services for patients with chronic kidney failure. The company operates primarily through its US Dialysis and Related Lab Services segment, delivering dialysis treatments at out..
>Volltext.. |
| 8700.15 Mio. EUR |
| 20701.18 Mio. EUR |
| 11819.19 Mio. EUR |
| 2361.54 Mio. EUR |
| 625.31 Mio. EUR |
| 8.46 EUR |
| 11326.43 Mio. EUR |
| 656.45 Mio. EUR |
| 1635.64 Mio. EUR |
| 0.25 |
| -6.17% |
| -32.05% |
| - |
| - |
| - |
| - |
| DAVITA |
| 05.04.26 |
|
||||
|
||||
|